Patents Assigned to Phovitreal Pty Ltd
  • Treatment or prophylaxis of a neurological or neuropsychiatric disorders via ocular administration
    Patent number: 9827210
    Abstract: A method for the treatment and/or prophylaxis of a neurological and/or neuropsychiatric disorder associated with altered dopamine function comprising administering to the eye of a patient in need thereof an effective amount of an agent that modulates neurotransmitter production or function.
    Type: Grant
    Filed: June 30, 2008
    Date of Patent: November 28, 2017
    Assignee: Phovitreal Pty Ltd
    Inventor: Gregory Lynn Willis